Clinical Trials Browser

Phase 1 × OTHER_GOV × pembrolizumab × Clear all

NCT05701527 2026-02-05

A Study of EBC-129 in Advanced Solid Tumours

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumours

NCT02521844 2024-10-08

A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours

Phase 1 Active not recruiting

Ovarian Neoplasms, Endometrial Neoplasms